Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
LUCID DIAGNOSTICS INC.
AI Executive Summary
AI-powered analysis of 8-K filing content
Lucid Diagnostics Inc. entered into a material underwriting agreement with Canaccord Genuity LLC and BTIG, LLC on April 23, 2026, to conduct an underwritten public offering of common stock at $1.00 per share. This capital-raising initiative is designed to strengthen the company's balance sheet and fund growth initiatives.
Key Takeaways
Lucid Diagnostics is raising capital through an underwritten public offering at $1.00 per share
Canaccord Genuity LLC and BTIG, LLC are serving as underwriter representatives
2 more takeaways